Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bao, J.-J.
Right arrow Articles by Bast, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bao, J.-J.
Right arrow Articles by Bast, R. C., Jr.
[Cancer Research 62, 7264-7272, December 15, 2002]
© 2002 American Association for Cancer Research


Experimental Therapeutics

Reexpression of the Tumor Suppressor Gene ARHI Induces Apoptosis in Ovarian and Breast Cancer Cells through a Caspase-independent Calpain-dependent Pathway1

Jia-Ju Bao, Xiao-Feng Le, Rui-Yu Wang, Jiuhong Yuan, Lin Wang, Edward N. Atkinson, Ruth LaPushin, Michael Andreeff, Bingliang Fang, Yinhua Yu and Robert C. Bast, Jr.2

Departments of Experimental Therapeutics [J-J. B., X-F. L., J. Y., L. W., Y. Y. and R. C. B.], Blood and Marrow Transplantation [R-Y. W., M. A.], Thoracic and Cardiac Surgery [B. F.], Biomathematics [E. N. A.], and Molecular Therapeutics [R. L.], University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

ARHI, an imprinted putative tumor suppressor gene, encodes a Mr 26,000 GTP-binding protein that is 60% homologous to ras and rap but has a dramatically different function. ARHI expression is down-regulated in a majority of breast and ovarian cancers. Using a dual adenovirus system, we have reexpressed ARHI in ovarian cancer and breast cancer cells that have lost ARHI expression. Reexpression of ARHI inhibited growth, decreased invasiveness, and induced apoptosis. At 5 days after infection with ARHI adenovirus, 30–45% of MDA-MB-231 breast cancer cells and 5–11% of SKOv3 ovarian cancer cells were apoptotic as judged by a terminal deoxynucleotidyl transferase-mediated nick end labeling assay and by Annexin V staining with flow cytometric analysis. Although poly(ADP-ribose) polymerase could be detected immunohistochemically in the nuclei of apoptotic cells, no activation of the effector caspases (caspase 3, 6, 7, or 12) or the initiator caspases (caspase 8 or 9) could be detected in cell lysates using Western blotting. When gene expression was analyzed on a custom cDNA array that contained 2304 known genes, infection with ARHI adenovirus up-regulated 15 genes relative to control cells infected with LacZ adenovirus. The greatest degree of mRNA up-regulation was observed in a Homo sapiens calpain-like protease. On Western blot analysis, calpain protein was increased 2–3-fold at 3–5 days after infection with ARHI adenovirus. No increase in calpain protein was observed after LacZ adenovirus infection. Calpain cleavage could be detected after ARHI reexpression, and inhibitors of calpain, but not inhibitors of caspase, partially prevented ARHI-induced apoptosis. Consequently, reexpression of ARHI in breast and ovarian cancer cells appears to induce apoptosis through a caspase-independent, calpain-dependent mechanism.




This article has been cited by other articles:


Home page
Mol Hum ReprodHome page
I. Penna, H. Du, R. Ferriani, and H. S. Taylor
Calpain5 expression is decreased in endometriosis and regulated by HOXA10 in human endometrial cells
Mol. Hum. Reprod., October 1, 2008; 14(10): 613 - 618.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Lu, R. Z. Luo, H. Peng, D. G. Rosen, E. N. Atkinson, C. Warneke, M. Huang, A. Nishmoto, J. Liu, W. S-L. Liao, et al.
Transcriptional and Posttranscriptional Down-Regulation of the Imprinted Tumor Suppressor Gene ARHI (DRAS3) in Ovarian Cancer
Clin. Cancer Res., April 15, 2006; 12(8): 2404 - 2413.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Nishimoto, Y. Yu, Z. Lu, X. Mao, Z. Ren, S. S. Watowich, G. B. Mills, W. S-L. Liao, X. Chen, R. C. Bast Jr., et al.
A Ras Homologue Member I Directly Inhibits Signal Transducers and Activators of Transcription 3 Translocation and Activity in Human Breast and Ovarian Cancer Cells
Cancer Res., August 1, 2005; 65(15): 6701 - 6710.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Elam, L. Hesson, M. D. Vos, K. Eckfeld, C. A. Ellis, A. Bell, D. Krex, M. J. Birrer, F. Latif, and G. J. Clark
RRP22 Is a Farnesylated, Nucleolar, Ras-Related Protein with Tumor Suppressor Potential
Cancer Res., April 15, 2005; 65(8): 3117 - 3125.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
S. Fujii, R. Z. Luo, J. Yuan, M. Kadota, M. Oshimura, S. R. Dent, Y. Kondo, J.-P. J. Issa, R. C. Bast Jr, and Y. Yu
Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylation
Hum. Mol. Genet., August 1, 2003; 12(15): 1791 - 1800.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Yuan, R. Z. Luo, S. Fujii, L. Wang, W. Hu, M. Andreeff, Y. Pan, M. Kadota, M. Oshimura, A. A. Sahin, et al.
Aberrant Methylation and Silencing of ARHI, an Imprinted Tumor Suppressor Gene in which the Function Is Lost in Breast Cancers
Cancer Res., July 15, 2003; 63(14): 4174 - 4180.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.